Dr Chi Udeh-Momoh is a Neuroscientist based at Imperial College London, and affiliated as a Senior Scientist with Karolinska Institutet and University of Bristol. She is co-Investigator and scientific coordinator of one of the world’s largest longitudinal dementia-prevention programmes (CHARIOT:PRO) with > 2000 cognitively healthy older adults screened, and data on imaging and fluid biomarkers as well as neurocognitive and lifestyle factors collected at high throughput. In 2018, she initiated the FINGER-AFRICA project that aims to develop and implement culturally-sensitive and sustainable multimodal lifestyle intervention strategies targeting multi-morbidities including dementia, in Sub-Saharan African populations, and investigate underlying mechanisms contributing to observed effects, with European, US and African collaborators. Having completed a competitive CASE PhD studentship in Neuroscience and Neuroendocrinology at the MRC Centre for Synaptic Plasticity at the University of Bristol, her current research focuses on the brain-immune-endocrine system interplay in the aetiology and pathophysiology of neurocognitive disorders, particularly Alzheimer’s disease. She is co-Lead for the World-Wide FINGERS biomarker consortium, and sits on the Executive Committee of the Biofluids-based Professional Interest Area for Alzheimer’s Association facilitating several biomarker workgroups, including the saliva biomarkers for dementia and exosome work group. She uses translational research methodologies to address gaps in current understanding of underlying bio-psychosocial factors involved in manifestation of pathology and resultant presentation of clinical symptoms, primarily in the context of brain and cognitive reserve-related mechanisms, also evaluating sex/gender differences in risk factors and biological pathways; and has published as lead, senior and corresponding author in this field, with several grants and awards to execute this work. She is incredibly passionate about gender and racial disparities in medical research and academia; and alongside research in this area leads diversity initiatives as part of the Opportunity Committee at Imperial College School of Public Health, and further sits on the Board of Trustees of the British Society of Neuroendocrinology as the Equality and Diversity Inclusion Lead.
et al., 2022, Evidence-Based Tools for Dietary Assessments in Nutrition Epidemiology Studies for Dementia Prevention, The Journal of Prevention of Alzheimer's Disease, ISSN:2274-5807
et al., 2022, At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer’s Disease and Related Research, The Journal of Prevention of Alzheimer's Disease, ISSN:2274-5807
et al., 2021, Health, lifestyle and psycho-social determinants of poor sleep quality during the Early Phase of the COVID-19 pandemic: a focus on UK older adults deemed clinically extremely vulnerable, Frontiers in Public Health, Vol:9, ISSN:2296-2565, Pages:1-11
Udeh-Momoh C, Watermeyer T, 2021, Female specific risk factors for the development of Alzheimer's disease neuropathology and cognitive impairment: Call for a precision medicine approach, Ageing Research Reviews, Vol:71, ISSN:1568-1637
et al., 2021, The impact of social restrictions during the COVID-19 pandemic on the physical activity levels of adults aged 50-92 years: a baseline survey of the CHARIOT COVID-19 Rapid Response prospective cohort study, Bmj Open, Vol:11, ISSN:2044-6055, Pages:1-12